Global Alpha- Antitrypsin Deficiency Treatment Market Research Report 2018

Global Alpha- Antitrypsin Deficiency Treatment Market Research Report 2018

In this report, the global Alpha- Antitrypsin Deficiency Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Alpha- Antitrypsin Deficiency Treatment in these regions, from 2013 to 2025 (forecast), covering North America Europe China Japan Southeast Asia India Global Alpha- Antitrypsin Deficiency Treatment market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Adverum Biotechnologies, Inc. Alnylam Pharmaceuticals, Inc. Applied Genetic Technologies Corporation Arrowhead Pharmaceuticals, Inc. Carolus Therapeutics, Inc. Cevec Pharmaceuticals GmbH Dicerna Pharmaceuticals, Inc. Digna Biotech, S.L. Editas Medicine, Inc. Grifols, S.A. Inhibrx Intellia Therapeutics, Inc. International Stem Cell Corporation Ionis Pharmaceuticals, Inc. Kamada Ltd. Polyphor Ltd. ProMetic Life Sciences Inc. rEVO Biologics, Inc. Sangamo BioSciences, Inc. On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into CT-2009 POL-6014 ARO-AAT ALNAAT-02 Others On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including Clinic Hospital Others If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents Global Alpha- Antitrypsin Deficiency Treatment Market Research Report 2018 1 Alpha- Antitrypsin Deficiency Treatment Market Overview 1.1 Product Overview and Scope of Alpha- Antitrypsin Deficiency Treatment 1.2 Alpha- Antitrypsin Deficiency Treatment Segment by Type (Product Category) 1.2.1 Global Alpha- Antitrypsin Deficiency Treatment Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 1.2.2 Global Alpha- Antitrypsin Deficiency Treatment Production Market Share by Type (Product Category) in 2017 1.2.3 CT-2009 1.2.4 POL-6014 1.2.5 ARO-AAT 1.2.6 ALNAAT-02 1.2.7 Others 1.3 Global Alpha- Antitrypsin Deficiency Treatment Segment by Application 1.3.1 Alpha- Antitrypsin Deficiency Treatment Consumption (Sales) Comparison by Application (2013-2025) 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Global Alpha- Antitrypsin Deficiency Treatment Market by Region (2013-2025) 1.4.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 1.4.2 North America Status and Prospect (2013-2025) 1.4.3 Europe Status and Prospect (2013-2025) 1.4.4 China Status and Prospect (2013-2025) 1.4.5 Japan Status and Prospect (2013-2025) 1.4.6 Southeast Asia Status and Prospect (2013-2025) 1.4.7 India Status and Prospect (2013-2025) 1.5 Global Market Size (Value) of Alpha- Antitrypsin Deficiency Treatment (2013-2025) 1.5.1 Global Alpha- Antitrypsin Deficiency Treatment Revenue Status and Outlook (2013-2025) 1.5.2 Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production Status and Outlook (2013-2025) 2 Global Alpha- Antitrypsin Deficiency Treatment Market Competition by Manufacturers 2.1 Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production and Share by Manufacturers (2013-2018) 2.1.1 Global Alpha- Antitrypsin Deficiency Treatment Capacity and Share by Manufacturers (2013-2018) 2.1.2 Global Alpha- Antitrypsin Deficiency Treatment Production and Share by Manufacturers (2013-2018) 2.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Share by Manufacturers (2013-2018) 2.3 Global Alpha- Antitrypsin Deficiency Treatment Average Price by Manufacturers (2013-2018) 2.4 Manufacturers Alpha- Antitrypsin Deficiency Treatment Manufacturing Base Distribution, Sales Area and Product Type 2.5 Alpha- Antitrypsin Deficiency Treatment Market Competitive Situation and Trends 2.5.1 Alpha- Antitrypsin Deficiency Treatment Market Concentration Rate 2.5.2 Alpha- Antitrypsin Deficiency Treatment Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue (Value) by Region (2013-2018) 3.1 Global Alpha- Antitrypsin Deficiency Treatment Capacity and Market Share by Region (2013-2018) 3.2 Global Alpha- Antitrypsin Deficiency Treatment Production and Market Share by Region (2013-2018) 3.3 Global Alpha- Antitrypsin Deficiency Treatment Revenue (Value) and Market Share by Region (2013-2018) 3.4 Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.5 North America Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.6 Europe Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.7 China Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.8 Japan Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.9 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.10 India Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 4 Global Alpha- Antitrypsin Deficiency Treatment Supply (Production), Consumption, Export, Import by Region (2013-2018) 4.1 Global Alpha- Antitrypsin Deficiency Treatment Consumption by Region (2013-2018) 4.2 North America Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018) 4.3 Europe Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018) 4.4 China Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018) 4.5 Japan Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018) 4.6 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018) 4.7 India Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018) 5 Global Alpha- Antitrypsin Deficiency Treatment Production, Revenue (Value), Price Trend by Type 5.1 Global Alpha- Antitrypsin Deficiency Treatment Production and Market Share by Type (2013-2018) 5.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Market Share by Type (2013-2018) 5.3 Global Alpha- Antitrypsin Deficiency Treatment Price by Type (2013-2018) 5.4 Global Alpha- Antitrypsin Deficiency Treatment Production Growth by Type (2013-2018) 6 Global Alpha- Antitrypsin Deficiency Treatment Market Analysis by Application 6.1 Global Alpha- Antitrypsin Deficiency Treatment Consumption and Market Share by Application (2013-2018) 6.2 Global Alpha- Antitrypsin Deficiency Treatment Consumption Growth Rate by Application (2013-2018) 6.3 Market Drivers and Opportunities 6.3.1 Potential Applications 6.3.2 Emerging Markets/Countries 7 Global Alpha- Antitrypsin Deficiency Treatment Manufacturers Profiles/Analysis 7.1 Adverum Biotechnologies, Inc. 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.1.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification 7.1.2.1 Product A 7.1.2.2 Product B 7.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.1.4 Main Business/Business Overview 7.2 Alnylam Pharmaceuticals, Inc. 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.2.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification 7.2.2.1 Product A 7.2.2.2 Product B 7.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.2.4 Main Business/Business Overview 7.3 Applied Genetic Technologies Corporation 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.3.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification 7.3.2.1 Product A 7.3.2.2 Product B 7.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.3.4 Main Business/Business Overview 7.4 Arrowhead Pharmaceuticals, Inc. 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.4.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification 7.4.2.1 Product A 7.4.2.2 Product B 7.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.4.4 Main Business/Business Overview 7.5 Carolus Therapeutics, Inc. 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.5.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification 7.5.2.1 Product A 7.5.2.2 Product B 7.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.5.4 Main Business/Business Overview 7.6 Cevec Pharmaceuticals GmbH 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.6.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification 7.6.2.1 Product A 7.6.2.2 Product B 7.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.6.4 Main Business/Business Overview 7.7 Dicerna Pharmaceuticals, Inc. 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.7.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification 7.7.2.1 Product A 7.7.2.2 Product B 7.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.7.4 Main Business/Business Overview 7.8 Digna Biotech, S.L. 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.8.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification 7.8.2.1 Product A 7.8.2.2 Product B 7.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.8.4 Main Business/Business Overview 7.9 Editas Medicine, Inc. 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.9.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification 7.9.2.1 Product A 7.9.2.2 Product B 7.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.9.4 Main Business/Business Overview 7.10 Grifols, S.A. 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.10.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification 7.10.2.1 Product A 7.10.2.2 Product B 7.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.10.4 Main Business/Business Overview 7.11 Inhibrx 7.12 Intellia Therapeutics, Inc. 7.13 International Stem Cell Corporation 7.14 Ionis Pharmaceuticals, Inc. 7.15 Kamada Ltd. 7.16 Polyphor Ltd. 7.17 ProMetic Life Sciences Inc. 7.18 rEVO Biologics, Inc. 7.19 Sangamo BioSciences, Inc. 8 Alpha- Antitrypsin Deficiency Treatment Manufacturing Cost Analysis 8.1 Alpha- Antitrypsin Deficiency Treatment Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Price Trend of Key Raw Materials 8.1.3 Key Suppliers of Raw Materials 8.1.4 Market Concentration Rate of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.3 Manufacturing Process Analysis of Alpha- Antitrypsin Deficiency Treatment 9 Industrial Chain, Sourcing Strategy and Downstream Buyers 9.1 Alpha- Antitrypsin Deficiency Treatment Industrial Chain Analysis 9.2 Upstream Raw Materials Sourcing 9.3 Raw Materials Sources of Alpha- Antitrypsin Deficiency Treatment Major Manufacturers in 2017 9.4 Downstream Buyers 10 Marketing Strategy Analysis, Distributors/Traders 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List 11 Market Effect Factors Analysis 11.1 Technology Progress/Risk 11.1.1 Substitutes Threat 11.1.2 Technology Progress in Related Industry 11.2 Consumer Needs/Customer Preference Change 11.3 Economic/Political Environmental Change 12 Global Alpha- Antitrypsin Deficiency Treatment Market Forecast (2018-2025) 12.1 Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue Forecast (2018-2025) 12.1.1 Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production and Growth Rate Forecast (2018-2025) 12.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate Forecast (2018-2025) 12.1.3 Global Alpha- Antitrypsin Deficiency Treatment Price and Trend Forecast (2018-2025) 12.2 Global Alpha- Antitrypsin Deficiency Treatment Production, Consumption , Import and Export Forecast by Region (2018-2025) 12.2.1 North America Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.2 Europe Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.3 China Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.4 Japan Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.5 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.6 India Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.3 Global Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Price Forecast by Type (2018-2025) 12.4 Global Alpha- Antitrypsin Deficiency Treatment Consumption Forecast by Application (2018-2025) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

Inquiry Before Buying

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Click Here

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?


Related Reports

  • $ 2900
  • $ 4200
  • $ 5800
Report ID 30071
Category
Published On 2018-01-12
No. of Pages 119
Publisher Name